The medication appears to counteract the metabolic adaptations that promote weight regain, potentially affecting what some researchers hypothesize as the body's defended weight
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug
Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV
P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about retatrutide as a potential treatment for adults with obesity or overweight and at least one weight-related comorbidity, potential efficacy and tolerability of retatrutide, and the timeline for future readouts, presentations, and other milestones relating to retatrutide and its clinical trials and reflects Lilly's current beliefs and expectations
It reports pathway-level variants in MTHFR, MTRR, and COMT that describe your baseline methylation and B12 biology, giving upstream context you can bring to a prescriber
